Tony Jourdan

2.5k total citations · 1 hit paper
38 papers, 2.0k citations indexed

About

Tony Jourdan is a scholar working on Pharmacology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tony Jourdan has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 13 papers in Surgery and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tony Jourdan's work include Cannabis and Cannabinoid Research (24 papers), Pancreatic function and diabetes (13 papers) and Diet, Metabolism, and Disease (12 papers). Tony Jourdan is often cited by papers focused on Cannabis and Cannabinoid Research (24 papers), Pancreatic function and diabetes (13 papers) and Diet, Metabolism, and Disease (12 papers). Tony Jourdan collaborates with scholars based in United States, France and Hungary. Tony Jourdan's co-authors include George Kunos, Grzegorz Godlewski, Reşat Çınar, Joseph Tam, Gergő Szanda, Bani Mukhopadhyay, Jie Liu, Pascal Degrace, Laurent Demizieux and Bruno Vergès and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Tony Jourdan

35 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes

2013 329 citations Tony Jourdan, Grzegorz Godlewski et al. profile →

Peers

Tony Jourdan

PHARM

EDM

SURGE

PHYSI

Gergő Szanda Hungary

Fatima Teixeira-Clerc France

Christine Reynet United States

Sören Siegmund Germany

Ewa Harasim‐Symbor Poland

Kirk M. Habegger United States

Anita M. van den Hoek Netherlands

Maria Sörhede Winzell Sweden

Dipanjan Chanda South Korea

Anna Iacono Italy

Gergő Szanda Hungary

Tony Jourdan

642 ×0.6

PHARM

387 ×0.7

EDM

408 ×0.8

SURGE

886 ×1.8

349 ×0.9

PHYSI

Citations per year, relative to Tony Jourdan Tony Jourdan (= 1×) peers Gergő Szanda

Countries citing papers authored by Tony Jourdan

Since Specialization

Citations

This map shows the geographic impact of Tony Jourdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Jourdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Jourdan more than expected).

Fields of papers citing papers by Tony Jourdan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Jourdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Jourdan. The network helps show where Tony Jourdan may publish in the future.

Co-authorship network of co-authors of Tony Jourdan

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Jourdan. A scholar is included among the top collaborators of Tony Jourdan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Jourdan. Tony Jourdan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Basu, Abhishek, Muhammad Arif, Ricardo Pineda, et al.. (2025). Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis. JCI Insight. 10(15).

Dvorácskó, Szabolcs, Luca Maccioni, Grzegorz Godlewski, et al.. (2025). Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders. Journal of Medicinal Chemistry. 68(20). 21224–21248.

Barbosa, Regina María, Marie‐Anne Loriot, Julia Leemput, et al.. (2025). A Simplified and Robust Model for the Study of Diabetic Nephropathy: Streptozotocin-Induced Diabetic Mice Fed a High-Protein Diet. International Journal of Molecular Sciences. 26(6). 2477–2477.

Dvorácskó, Szabolcs, Biswajit Kundu, Henry L. Puhl, et al.. (2025). Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders. Metabolism. 170. 156291–156291. 1 indexed citations

Farokhnia, Mehdi, Tony Jourdan, Grzegorz Godlewski, et al.. (2023). A human laboratory study on the link between alcohol administration and circulating fibroblast growth factor 21 (FGF21) in individuals with alcohol use disorder. Drug and Alcohol Dependence. 245. 109809–109809. 7 indexed citations

Passilly‐Degrace, Patricia, Julia Leemput, Laurent Demizieux, et al.. (2023). Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy. SHILAP Revista de lepidopterología. 3. 11 indexed citations

Szanda, Gergő, Tony Jourdan, Éva Wisniewski, et al.. (2023). Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3. iScience. 26(7). 107207–107207. 3 indexed citations

Zhou, Wenhao, Yuan Luo, Ruixin Li, et al.. (2023). Inhibition of mitochondrial fatty acid β-oxidation activates mTORC1 pathway and protein synthesis via Gcn5-dependent acetylation of Raptor in zebrafish. Journal of Biological Chemistry. 299(10). 105220–105220. 11 indexed citations

Demizieux, Laurent, Julia Leemput, Christine Belloir, et al.. (2022). Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist. International Journal of Molecular Sciences. 23(6). 2923–2923. 7 indexed citations

10.

Liu, Ziyi, Malliga R. Iyer, Grzegorz Godlewski, et al.. (2021). Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB₁R) Antagonist. ACS Pharmacology & Translational Science. 4(3). 1175–1187. 43 indexed citations

11.

Leemput, Julia, Patricia Passilly‐Degrace, Pablo Ortega‐Deballon, et al.. (2021). Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human. Frontiers in Endocrinology. 12. 716431–716431. 9 indexed citations

12.

Godlewski, Grzegorz, Reşat Çınar, Nathan J. Coffey, et al.. (2019). Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis. Cell Metabolism. 29(6). 1320–1333.e8. 45 indexed citations

13.

Çınar, Reşat, Bernadette R. Gochuico, Malliga R. Iyer, et al.. (2017). Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis. JCI Insight. 2(8). 68 indexed citations

14.

Çınar, Reşat, Malliga R. Iyer, Ziyi Liu, et al.. (2016). Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis. JCI Insight. 1(11). 63 indexed citations

15.

Çınar, Reşat, Grzegorz Godlewski, Jie Liu, et al.. (2013). Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides. Hepatology. 59(1). 143–153. 144 indexed citations

16.

Tam, Joseph, Reşat Çınar, Jie Liu, et al.. (2012). Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance. Cell Metabolism. 16(2). 167–179. 296 indexed citations

17.

Jourdan, Tony, et al.. (2011). Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: Evidence from cultured explants. Hepatology. 55(3). 790–799. 55 indexed citations

18.

Jourdan, Tony, Laurent Demizieux, Michaël Chevrot, et al.. (2010). Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants. Diabetes/Metabolism Research and Reviews. 26(4). 297–305. 16 indexed citations

19.

Sáez, Guillermo T., S. Davail, Jean-François J.-F. Hocquette, et al.. (2009). Gene expression and protein content in relation to intramuscular fat content in Muscovy and Pekin ducks. Poultry Science. 88(11). 2382–2391. 48 indexed citations

20.

Jourdan, Tony, et al.. (2009). Liver Carbohydrate and Lipid Metabolism of Insulin-Deficient Mice Is Altered by trans-10, cis-12 Conjugated Linoleic Acid ,. Journal of Nutrition. 139(10). 1901–1907. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact